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Abstract A facile, rapid, solution-phase method of
detecting human cardiac troponin I for sensing myocardial
damage has been described using gold nanorods-based
biosensors. The sensing is demonstrated by the distinct
change of the longitudinal surface plasmon resonance
wavelength of the gold nanorods to speciﬁc antibody–
antigen binding events. For a higher sensitivity, the aspect
ratio of gold nanorods is increased up to ca 5.5 by simply
adding small amount of HCl in seed-mediated growth
solution. Experimental results show that the detecting limit
of the present method is 10 ng/mL. Contrast tests reveal
that these gold nanorods-based plasmonic biosensors hold
much higher sensitivity than that of conventionally spher-
ical gold nanoparticles.
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Introduction
Cardiac troponin I (cTnI) is a protein subunit of cardiac
troponin complex. During the myocardial damage process,
the troponin complex is broken up, and the individual
protein components including cTnI are released into the
bloodstream [1]. Early detection of cTnI in the serum of
patients with a higher risk of acute myocardial infarction
can decrease the danger of death from heart attack.
Because of high tissue speciﬁcity that ensuring an accurate
assay, cTnI has been considered as the ‘‘gold standard’’ of
cardiac marker for clinic diagnosis of acute myocardial
damage [2–4]. Currently, most cTnI detections are based
on the traditional enzyme linked immunosorbent assay
(ELISA) methods. For a typical ELISA process, a capture
anti-cTnI antibody against cTnI is ﬁrstly immobilized onto
the surface of plastic well, followed by adding a patient
sample containing cTnI for binding the capture anti-cTnI
antibody. Then an enzyme labeled detector anti-cTnI
antibody is allowed to bind with the immobilized cTnI. In
each step mentioned above, quite a few wash cycles are
necessary in order to remove the unbound antibody or
antigen from the well. Finally, enzymatic substrate is
added, and cTnI is detected by an enzyme-dependent color-
change reaction. The entire ELISA process can usually take
several hours to days to accomplish, which is labor-inten-
sive and time-consuming. To overcome these limitations, it
is of signiﬁcance to develop a convenient, rapid and
homogeneous immunoassays strategy for detecting cTnI
events.
In recent years, biomedical research has received a large
advancement, which greatly beneﬁt from the development
of nanomaterials [5–7]. Among these nanomaterials, gold
nanoparticles (NPs) hold unique optical properties called
localized surface plasmon resonance (LSPR) arising from
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and facile surface modiﬁcation, enabling them quite suit-
able nanoscale platforms for biosensing or antibody–anti-
gen immunoassay [8]. In general, the label-free sensing
using gold NPs can be achieved by analyte-mediated gold
NPs aggregation. This concept is that the surface of the
gold NPs needs to be modiﬁed with recognition molecules
that speciﬁcally bind the analyte of interest. The recogni-
tion molecules-modiﬁed gold NPs will be brought very
close to each other by recognition molecule-target molec-
ular conjugation after adding the analyte solution, which
brings on the coupling of plasmon resonances from adja-
cent NPs. As a result, the SPR band(s) of aggregated gold
NPs will be broadened and red-shifted as a function of the
amount of analyte. These changes can be recorded on a
conventional UV–visible spectrophotometer [9]. As a face-
centered cubic metal with intrinsically high symmetry, the
most common and easily obtained shape of gold NPs is a
spherical one. For this main reason, spherical gold NPs are
involved in most of the exiting works utilizing gold NPs
aggregation effects to sense speciﬁc target binding events
so far. Recently, both experimental and computational
studies have revealed that the shape of gold NPs plays a
key role in determining their optical properties [8, 10–12].
In particular, gold NPs with elongated shape called nano-
rods (NRs) have attracted much attention, because their
highly anisotropic shape exhibits specially optical proper-
ties that are much different from commonly spherical ones
[13]. For instance, gold NRs show two distinct LSPR bands
owing to the transverse and the longitudinal oscillation of
the electrons respectively, one at short wavelength about
510 nm and the other at long wavelength beyond 600 nm,
whereas spherical gold NPs displays only one band around
520 nm. In terms of LSPR sensing, there are several
advantages to gold NRs compared to spherical NPs. First of
all, the longitudinal SPR band of gold NRs has a higher
sensitivity to the changes of the local dielectric surround-
ings, including solvent, adsorbed molecules and the
aggregate state, when compared to similar-sized spherical
NPs [14–16]. Since the longitudinal and transverse LSPR
bands of gold NRs are basically independent of each other,
one can use the changes of the longitudinal SPR band for
more sensitive detection of target molecules. Secondly, it is
also observed that this sensitivity of longitudinal band
increases with higher aspect ratio (length divided by width,
denoted as AR), leading to an improved detection sensi-
tivity [17, 18]. In addition, increasing the AR of gold NRs
can easily tailor the longitudinal SPR band from the visible
to the near infrared (NIR) region (700–1,000 nm), which is
a transparent window for hemoglobin and facilitate the
detection of whole blood samples [19]. Thirdly, because
spherical shape has the smallest surface area relative to
objects of other shapes (when the volume is ﬁxed), gold
NRs give a much larger surface area compared with
spherical ones for adsorption of protein. Thanks to the
efforts of many research groups, gold NRs can be synthe-
sized routinely with high monodispersity at present time,
which is an essential factor for using gold NR as LSPR
sensors.
In this letter, we describe a convenient and rapid method
for human cTnI detection in solution using anti-human
cTnI immunogold NRs. The sensing was based on changes
of longitudinal LSPR band induced by speciﬁc anti-h-cTnI
antibody-h-cTnI binding events. To our knowledge, it is
the ﬁrst report of taking advantage of gold NRs for sensing
h-cTnI. In order to improve the sensitivity, gold NRs with a
higher AR ca. 5.5 are fabricated successfully by adding
small amount of HCl in the growth solution through a
modiﬁed seed-mediated approach. The detection limit of
the present method is 10 ng/mL, which exhibits much
higher sensitivity of detecting h-cTnI events than that of
spherical gold NPs.
Experimental Sections
Materials
Cetyltrimethylammonium bromide (CTAB, 99%, Cat No:
H6269) and Poly(styrenesulfonate) (PSS, Mw 70,000)
were purchased from Sigma. Hydrogen tetrachloroauric
acid (HAuCl44H2O, 99%), hydrochloric acid (HCl),
sliver nitrate, sodium borohydride (NaBH4, 96%) and
L-ascorbic acid (AA) were all purchased from Shanghai
Chemical Reagent Co. Ltd (China). Millipore-quality
water (18.18 MX/cm) was used throughout the experi-
ments. cTnI from human myocardium muscle and the
monoclonal anti-human cTnI antibodies used in the exper-
iment were obtained from Research Institute of Cardio-
vascular Disease of First Afﬁliated Hospital of Nanjing
Medical University.
Fabrication of Monodisperse Gold NRs
Gold NRs were fabricated based on a seed mediated,
CTAB-assisted growth procedure by Nikoobakht et al. [20]
with some modiﬁcations. Gold seed solution was prepared
ﬁrst by adding 0.6 mL of ice-cold solution of 10 mM
NaBH4 to 10 mL of 0.25 mM HAuCl4 prepared in 0.1 M
CTAB solution, under vigorous stirring for 2 min. The
yellow color changed immediately to brown, indicating the
formation of gold seeds. These seeds were aged for 2 h in
order to allow the hydrolysis of unreacted NaBH4,The
growth procedure was scaled up to obtain a 100 mL dis-
persion of the gold NRs. Brieﬂy, the solutions were added
to a 250 mL conical ﬂask, in the following order: 100 mL
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solution, 2 mL of 25 mM aqueous HAuCl4 and 0.4 mL of
1 M HCl solution. To this was added 0.70 mL of 0.0788 M
AA as reducing agent, and the mixture was homogenized
by stirring gently. Finally, 120 lL of seed solution was
added, and the whole solution was left undisturbed over-
night (14–16 h).
PSS Coating
Typically, 10 mL of as-fabricated gold NRs was centri-
fuged at 13,000 g/min for 20 min, the supernatant was
discarded, and the precipitate was redispersed in 5 mL of
Milli-Q water. Subsequently, it was added dropwise to
1 mL of PSS (2.5 mg/L,) aqueous solution under vigorous
stirring. After adding PSS solution, the mixture was kept
undisturbed for 0.5 h. Then, it was centrifuged twice at
12,500 g/min to remove excess polyelectrolyte and dis-
persed in 5 mL of Tris buffer (pH = 8.2).
Conjugation of Anti-h-cTnI Antibody with PSS-capped
Gold NRs
The PSS-capped gold NRs were mixed with excess amount
of anti-h-cTnI solution (50 lg/mL in Tris buffer) for
30 min under magnetic stirring. The mixture was centri-
fuged in order to remove unbinding antibodies and redi-
spersed into Tris buffer. Finally, these antibody conjugated
gold NRs were store at 4 C for further utilization.
Binding of h-cTnI to Anti-h-cTnI Antibody Conjugated
Gold NRs
In each experiment, 1.0 mL of anti-cTnI antibody conju-
gated gold NRs was added to a ﬁxed amount (1, 10, 100,
200, 400, 500 ng) of h-cTnI under vortex mixing. The
resultant mixture was incubated for 15 min before
recording with 2802S (UNICO) spectrophotometer.
Characterization
Transmission electron microscopy (TEM) images were
taken with a JEM-2000EX (JEOL) transmission electron
microscope operated at 120 kV. The samples were pre-
pared by dropping the dispersion of gold products onto the
carbon-coated copper grid and dried in ambience. UV–vis–
NIR spectra were recorded on a 2802S (UNICO) spectro-
photometer in the 300–1,100 nm range. Fourier transform
infrared (FTIR) spectra were measured on a Magna FTIR-
750 (Nicolet) spectrometer, and the vacuum-dried sample
was made in the form of a KBr pellet.
Results and Discussion
Fabrication, Surface Functionalization and
Characterization of Gold NRs
According to the seed mediated, CTAB-assisted growth
approach by Nikoobakht et al. [20], the AR of gold NR can
be increased up to 4.5 by adjusting the amount of silver.
Thus, our ﬁrst aim is to fabricate gold NRs with AR 4.5 for
higher detection sensitivity. However, we could only
obtain gold NRs with AR 3.5 when adopting the same
recipe by Nikoobakht et al. (Fig. 1). Very recently, Smith
and Korgel demonstrated that iodide impurity at ppm
concentrations present in CTAB prevents gold NRs for-
mation [21]. It has been found that iodide tends to adsorb
onto the {111} facets—the end surface of the gold NRs—
and slows the gold deposition rate on these facets, which
results in either gold NRs with lower AR or even spherical
gold NPs [21]. To overcome this problem, we add a small
amount of HCl solution to the growth solution for
decreasing the whole reduction rate, because AA has a
much weaker reducing power in strong acidic solution than
in weak acidic solution [13, 22]. By doing this, we presume
that the growth rate of the lateral surfaces of gold NRs,
such as {110} facets, could fall down correspondingly and
facilitate the formation of gold NRs with a higher AR.
Figure 2 shows the effect of adding identical growth
solutions to 0–0.8 mL of 1 M HCl solution. It can be seen
that by increasing the HCl amount, the longitudinal LSPR
band red shifts dramatically from 710 up to 856 nm. Cor-
respondingly, the average AR of gold NRs rises from 3.5 to
5.5 by TEM observation. In all the samples, the fraction of
NR-shaped gold particles consisting of spheres and cubes
is less than 3%. In this research, the as-fabricated gold
NRs with AR 5.5 have been chosen to use in the whole
Fig. 1 TEM image of gold NRs fabricated without adding HCl to the
growth solution
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bilayers and are positively charged on the surface [22].
Although there are some publications describe that the
washed CTAB-capped gold NRs are found to be nontoxic
and able to conjugate antibody protein directly [23, 24], our
tests do reveal that the CTAB on the gold NRs cause the
denaturation and sedimentation of anti-h-cTnI antibodies.
To passivate the cytotoxicity of CTAB, anionic polyelec-
trolyte PSS has been coated on the surface of gold NRs by
electrostatic interaction before antibody conjugation. The
conjugation of antibody on the PSS-coated gold NRs
possibly lies in two interactions illustrated in Fig. 3:
(1).The electrostatic interaction between the negatively
charged PSS and the positively charged segment of the
antibody; (2). The hydrophobic interaction between PSS
and the antibody [25, 26]. Figure 4 shows the absorption
spectra of gold NRs before and after PSS coating and
subsequent antibody conjugation. The longitudinal LSPR
absorption maximum has a 28 nm blue shift after PSS
coating (Fig. 4b). After anti-h-cTnI antibody conjugating
to the PSS layer, there is an 18 nm red shift of the longi-
tudinal LSPR absorption maximum (Fig. 4c). No shift in
the absorption maximum of the transverse LSPR is
observed during the whole process, indicating that the
longitudinal SPR of gold NRs is extremely sensitive to the
changes of the local dielectric surrounding. FTIR mea-
surements have been performed on the CTAB gold NRs
before and after PSS coating and subsequent anti-h-cTnI
antibody conjugation. It can be seen clearly that sharp
characteristic peaks of different functional groups emerge
after the conjugation of antibody on the PSS-coated gold
NRs, which conﬁrms the formation of NR-bound antibody
composites (Supplementary material, Fig. S1). TEM ima-
ges have been recorded for the CTAB-capped gold NRs
before (Fig. 5a) and after surface modiﬁcation by PSS
(Fig. 5b) and subsequent anti-h-cTnI antibody (Fig. 5c) in
turn. Both CTAB-capped gold NRs and PSS-coated gold
NRs can be clearly seen from the TEM images (Fig. 5a,b).
However, the image of gold NRs after antibody conjuga-
tion is quite obscure (Fig. 5c), due to the large size and
nonconductibility of the antibodies.
Detection of h-cTnI Using Anti-h-cTnI Antibody
Conjugated Gold NRs in Solution
Figure 6 reveals the changes in the absorbance of the anti-h-
cTnI antibody conjugated gold NRs solution after the
addition of h-cTnI at different concentrations. It can be seen
the longitudinal SPR band is continuously red-shifted (from
846 to 866 nm) and decreases in intensity distinctly due to
the antibody–antigen recognition event, when increasing
the concentration of h-cTnI from 1 to 200 ng/mL. The
spectra results indicate that the speciﬁc detection of h-cTnI
Fig. 2 Effect of the HCl concentration on the UV–vis–NIR absorp-
tion spectra of gold NRs. The longitudinal SPR band red shifts by
increasing the amount of 1 M HCl solution added: a 0 mL; b 0.1 mL;
c 0.2 mL; d 0.4 mL; e 0.8 mL
Fig. 3 Schematic illustration of conjugation of PSS-coated gold NRs
with anti-h-cTnI antibody
Fig. 4 UV–vis–NIR absorption spectra of gold NRs at different
stages of surface functionalization: a as-fabricated gold NRs with
average AR 5.5; b PSS-coated gold NRs and c anti-h-cTnI antibody
conjugated gold NRs
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of 10 ng/mL. Furthermore, broadening of the longitudinal
band is also observed under high concentration of h-cTnI
([200 ng/ml), which might be due to the aggregation of
gold NRs driven by the increasing speciﬁc binding events
of anti-h-cTnI antibody and h-cTnI. To investigate the
nonspeciﬁc adsorption of other proteins on the anti-h-cTnI
antibody conjugated gold NRs, control experiment has been
conducted by detecting goat IgG instead of h-cTnI, and
longitudinal SPR band change is observed (Supplementary
material, Fig. S2). These results conﬁrm that the changes in
longitudinal band of gold NRs arise from the speciﬁc rec-
ognition between anti-h-cTnI antibody and h-cTnI. More-
over, we have also used spherical, citrate-stabilized gold
NPs with a diameter of 20 nm as platforms for sensing
h-cTnI. The experimental results show that corresponding
changes in the LSPR band are quite weak compared with
that of gold NRs at the same detecting concentrations
(Fig. 7), indicating that the gold NRs-based biosensors are
more effective for detecting cTnI events.
Fig. 5 TEM images of gold NRs with different surface coating:
aas-synthesized,CTAB-capped goldNRswithaverageAR5.5,bafter
PSS coating and subsequent, c anti-h-cTnI antibody conjugation
Fig. 6 UV–vis–NIR absorbance spectra for a gold NRs after
conjugation of anti-cTnI antibody, and b–g the gold NRs conjugated
with anti-h-cTnI antibody after treatment with h-cTnI (1, 10, 100,
200, 400 and 500 ng/mL in Tris buffer, respectively)
Fig. 7 UV–vis–NIR absorbance spectra for a uncapped spherical
gold NPs, b spherical gold NPs after conjugation of anti-h-cTnI
antibody and c–f the gold nanoparticles conjugated with anti-h-cTnI
antibody after treatment with h-cTnI (1, 10, 100, 200 ng/mL in Tris
buffer, respectively)
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In summary, we have described here a rapid and sensitive
method of detecting human cTnI for sensing myocardial
damage. This method is based on the changes of longitu-
dinal SPR band of gold NRs induced by the anti-h-cTnI
antibody-h-cTnI recognition events. For purpose of
improving the detect sensitivity, the average AR of gold
NRs is adjusted to 5.5 by adding a proper amount of HCl to
the seed-mediated growth solution. The detection limit of
the present method is 10 ng/mL. Contrast tests reveal
clearly that these gold NRs-based biosensors are more
sensitive for detecting cTnI events compared with that of
spherical gold NPs. We are currently conducting studies for
multiplex detection of the biomarkers of coronary syn-
drome by utilizing the AR dependence of the longitudinal
LSPR wavelength of gold NRs.
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